patho exam 4 Flashcards

1
Q

Steps in the Development of Disease

A

etiology: cause of disease -
hypoxia & ischemia
toxins
infections
abnormal immune rxns
genetic abnormalities
nutritional imbalances
physical agents

pathogenesis: mechanisms of disease
biochemical changes
structural changes

abnormalities in cells & tissues
molecular
functional
morphologic

clinical manifestations
signs & symptoms of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cellular Adaptation

A

Adapt to change in the internal environment
Adaptation includes changes in cells:
◼ Size
◼ Number
◼ Type

Changes may lead to
◼ Atrophy - decreased cell size
◼ Hypertrophy- increased cell size
◼ Hyperplasia- increased cell number
◼ Metaplasia - change from one adult cell type to another
◼ Dysplasia - cells of varying size, shape, and organization in a specific tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

normal myocyte and its progression

A

ischemia leading to cell injury =
- reversibly injured myocyte - then cell death

adaptation: response to increased load:
- adapted myocyte hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

parts in a tissue

A

basement membrane

normal columnar epithelium

squamous metaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cell Injury and Death

A

Cell injury may be reversible or irreversible

healthy cell + insult/injury <-> cell injury -> death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of cell injury

A

Hypoxia and ischemia
◼ Toxins
◼ Infectious agents
◼ Immunologic reactions
◼ Genetic abnormalities
◼ Nutritional imbalances
◼ Physical agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypoxia and ischemia

A

◼ Hypoxia: oxygen deficiency
◼ Ischemia: reduced blood supply (thus O2)
◼ Among the most common causes of cell injury
◼ Deprive tissues of O2
◼ Essential for generating E for cell function and survival
◼ Ischemia also reduces the nutrient supply
- e.g., artery blockage, lung disease, anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Toxins

A

Multiple sources:
◼ Air pollutants, insecticides, carbon monoxide, asbestos, cigarette smoke, ethanol, drugs

Multiple mechanisms:
◼ Direct damage to cell
◼ Enzyme interference
◼ Protein denaturation
◼ Disrupt cellular osmotic/ionic balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Infectious agents

A

◼ Viruses: DNA incorporation
◼ Bacteria: direct; exo-/endo-toxins
◼ Fungi
◼ Parasites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immunologic Reactions

A

◼ The good: immune responses to injury and infection are absolutely essential

◼ The bad: autoimmune reactions against one’s own tissues, allergic reactions against environmental substances, excessive or chronic immune responses to microbes

◼ Problem: immune responses elicit inflammatory reactions (which are good), but inflammation can damage cells and tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Genetic abnormalities

A

◼ Chromosomal (e.g., Down Syndrome) or single nucleotide mutations (e.g., sickle cell anemia)

◼ Role in CA development

Cell injury consequence of:
◼ decrease (e.g., enzymes in inborn errors of metabolism) or increase in protein function
◼ accumulation of damaged DNA or misfolded proteins can trigger cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nutritional imbalances

A

Deficiencies
◼ Vitamins
◼ Minerals
◼ Protein
◼ Carbohydrate
◼ Fat
◼ Starvation: all nutrients deficient

Excesses
◼ Obesity
◼ Saturated fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

physical agents

A

Trauma/Mechanical forces
◼ Impact with other objects

Temperature extremes
◼ Low-intensity heat
◼ More intense heat
◼ Cold

Radiation

Electrical injuries
◼ Voltage, amperage, AC vs. DC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Physical Agent: Radiation injury

A

Ionizing radiation: High frequency
◼ Free radical formation
Ultraviolet radiation
◼ Sunburns -> skin CA

Nonionizing radiation: Lower frequency (IR, ultrasound, microwaves, laser energy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Case: stresses and injury

A

◼ Homer Simpson has a terrible cold
◼ He starts a fire at his job in a nuclear power plant
◼ In attempting to put out the fire, Homer burns his hands and is exposed to ionizing radiation
◼ The nuclear plant is evacuated and Homer stands in the snow for 2 hours; he gets frostbite
◼ He is sent for treatment, where he develops a Clostridium infection in his burned hands
◼ What are the stressors on his cells and how are they causing cell damage?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanisms of Cell Injury: General Principles

A

◼ Cell response depends on type of injury, its duration, and severity
◼ Consequences depend on the type of cell and its metabolic state, adaptability, and genetic makeup
◼ Usually results from functional and biochemical abnormalities in one or more essential cellular components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mechanisms of cell injury

A
  1. Mitochondrial dysfunction and damage
  2. Oxidative stress
  3. Membrane damage
  4. Disturbance in calcium homeostasis
  5. ER stress
  6. DNA damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mechanisms of cell injury

A

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. Mitochondrial Dysfunction and Damage
A

Mechanism of injury: Failure of oxidative phosphorylation, leading to decreased ATP generation and depletion of ATP in cells
◼ “Power failure” in cell
◼ Oxidative metabolism falters; cell reverts to
anaerobic metabolism (less efficient; less E)
◼ pH falls due to lactic acid accumulation
◼ Effects: clumping of nuclear chromatin; destruction of cell membranes, intracellular components
◼ Loss of E: failure of Na+/K+-ATPase membrane pumps
◼ Cells swell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hypoxic cell injury

A

O2 deprivation
◼ Reduced aerobic metabolism ◼ Reduced ATP production
Reversible or irreversible, depending on:
◼ Degree of deprivation
◼ Metabolic needs of cells (high tissue O2 demands: Heart, brain, kidneys)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypoxic cell injury (cont.)

A

causes
◼ Low [O2] in air: “pure” hypoxia
◼ Respiratory disease
◼ Ischemia (decreased blood flow = circulatory disorders)
◼ Anemia
◼ Edema
1/24/2024

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

image

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  1. Oxidative Stress
A

◼ Oxidative stress = cellular damage induced by the accumulation of reactive oxygen species (ROS), a form of free radical
◼ Free radicals: Chemical species with free (unpaired) electron in outer orbit
(smoke, radiation)
◼ Protection: antioxidants

◼ Highly unstable; very reactive
◼ Normal cellular reactions produce free radicals
(cellular respiration, Mfs)
◼ Extrinsic factors can produce free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

principle of free radicals involved in cell injury

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q
  1. Membrane Damage
A

◼ Most forms of cell injury that end in cell death: characterized by increased membrane permeability → membrane damage
◼ Cell membranes may be damaged by: ROS, phospholipid biosynthesis, degradation, cytoskeletal abnormalities that disrupt the anchors for plasma membranes
◼ Most important sites of membrane damage: Mitochondrial membrane damage
Plasma membrane damage
Injury to lysosomal membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

image

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q
  1. Disturbance in calcium homeostasis
A

Importance of intracellular [Ca2+]
◼ Cellular messenger
◼ Stored in ER and mitochondria
Normally, intracellular [Ca2+] low vs. extracellular levels
◼ Maintained by Ca2+/Mg2+-ATPase exchange system
Toxins and ischemia can increase intracellular [Ca2+]
◼ Cell damage from activated enzymes: phospho- lipases, proteases, ATPases, endonucleases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q
  1. Endoplasmic Reticulum Stress
A

Protein synthesis in ER: chaperones enhance proper folding of newly synthesized proteins
◼ Process is imperfect; some misfolded polypeptides made
◼ Targeted for proteolysis by ubiquitination

Accumulated misfolded proteins in ER induce
protective cellular (adaptive) response = unfolded protein response
◼ Activates signaling pathways that increase the production of chaperones and retard protein translation, reducing levels of misfolded proteins
◼ If quantity of misfolded protein exceeds capacity of adaptive response, additional signals activate proapoptotic sensors →apoptosis (intrinsic, more later)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Unfolded Protein Response and ER Stress

A

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q
  1. DNA Damage
A

DNA damage may result from:
◼ Exposure of cells to radiation or chemotherapeutic agents ◼ Intracellular generation of ROS
◼ Acquisition of mutations

If severe damage: may trigger apoptotic death
Damage to DNA sensed by intracellular sentinel proteins, which transmit signals that lead to the
accumulation of p53 protein
◼ p53 first arrests the cell cycle (at the G1 phase) to allow the
DNA to be repaired before it is replicated
◼ If the damage is too great to be repaired successfully, p53
triggers apoptosis, mainly by the mitochondrial pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Reversible cell injury

A

Two patterns visible under microscope: ◼ Cellular swelling
◼ Impaired Na+/K+-ATPase pump, usually from hypoxia
◼ Fatty change: indicative of severe injury
◼ Many small vacuoles of fat in cytoplasm
◼ May be due to high fat load or reduced ability to metabolize fat
◼ Liver, heart, kidneys particularly susceptible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Cell death

A

Balance exists between death and proliferation

Cell death in two ways:
◼ Apoptosis: controlled cell destruction (“cell suicide”)
◼ Removes cells that are being replaced or have “worn out” ◼ Removes unwanted tissue
◼ Normal process in the body
◼ Necrosis: Unregulated death caused by injuries to
cells; death of organ or tissue that is part of a living
person
◼ Cells swell and rupture ◼ Inflammation results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

necrosis

A

cell size
- enlarged (swelling)

nucleus
- pyknosis to karyorrhexis to karyolysis

plasma membrane
- disrupted

cellular contents
- enzymatic digestion; may leak out of the cell

adjacent inflammation
- frequent

physiologic or pathologic role
- invariably pathologic (culmination of irreversible cell injury)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

apoptosis

A

cell size
- reduced (shrinkage)

nucleus
- fragmentation into nucleosome-sized fragments

plasma membrane
- intact; altered structure, esp. orientation of lipids

cellular contents
- intact; maybe released in apoptotic bodies

adjacent inflammation
- no

physiologic or pathologic role
- often physiological means of eliminating unwanted cells; may be pathologic after some forms of cell injury, esp. DNA & protein damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Apoptosis

A

◼ Programmed cell death via controlled cell destruction
◼ Physiologic:
◼ Development, maturation, repair
◼ Pathophysiologic:
◼ Lack of apoptosis in proliferation of CA cells ◼ Hepatocyte death in hepatitis B and C
◼ Control Mechanism: unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Apoptosis, the process

A

◼ Controlled autodigestion via endogenous enzymes
◼ Cell shrinkage:
◼ Disruption of cytoskeleton
◼ Condensation of cytoplasmic organelles
◼ Disruption and clumping of
nuclear DNA
◼ Eventually nucleus breaks into
spheres
◼ Wrinkling of cell membrane
◼ Finally: division of cell into membrane-covered fragment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Necrosis

A

Necrosis: death of organ or tissue that is part of a living person

Unregulated:
◼ Enzymatic digestion of cell components
◼ Loss of membrane integrity
◼ Uncontrolled release of products into intracellular space
◼ Initiation of inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Necrosis, different types

A

Liquefaction/liquefactive necrosis: e.g., center
of abscess
◼ Characterized by tissue softening
◼ Death of some cells but their catalytic enzymes
still functional
Coagulation necrosis: e.g., hypoxic
injury/infarct
◼ Transformation into gray, firm mass
◼ Acidosis, with resultant denaturation of proteins
Caseous necrosis: e.g., Tb granulomas
◼ Persistence of dead cells as soft, cheeselike debris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Necrosis, different types 2

A

Fat necrosis: Focal areas of fat destruction (due
to abdominal trauma or acute pancreatitis) ◼ Enzymes leak out of damaged pancreas, digest
peritoneal fat cells and their contents (e.g., stored
triglycerides)
◼ Released fatty acids combine w/ Ca2+: produce
grossly identifiable chalky white lesions
Fibrinoid necrosis: Special form of necrosis,
visible by light microscopy
◼ Seen in immune reactions, in which Ag/Ab
deposited bv walls, and in severe hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Gangrene

A

Describes large area of necrotic tissue

2 classifications:
◼ Dry gangrene: lack of arterial blood supply but
venous flow can carry fluid out of tissue ◼ Tissue tends to coagulate
◼ Moist (wet) gangrene: lack of venous flow lets fluid accumulate in tissue
◼ Tissue tends to liquefy; infection likely ◼ Special type:
◼ Gas gangrene: Clostridium infection produces toxins and H2S bubbles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Autophagy

A

Autophagy (“self-eating”): lysosomal digestion
of the cell’s own components
◼ Survival mechanism during nutrient deprivation ◼ Enables starved cell to live by eating its own
contents and recycling these contents to provide nutrients and E

Intracellular organelles and cytosol sequestered
within an ER-derived double membrane
(phagophore); matures into autophagic vacuole ◼ Fuses w/ lysosomes: forms autophagolysosome
◼ Digests cellular components w/in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Autophagy

A
43
Q

Cell Changes with Aging— Why?

A

Is it programmed into cells?
◼ Telomeres become too short; cell can no
longer divide
Is it the result of accumulated damage?
◼ Older cells have more DNA damage
◼ Older cells have more free radicals
◼ Cells lose the ability to repair their telomeres

44
Q

Aging: what we know

A

Results from combination of multiple and progressive cellular alterations
◼ Accumulation of DNA damage and mutations
◼ Replicative senescence: reduced capacity of cells to divide secondary to progressive shortening of chromosomal ends (telomeres)
◼ Defective protein homeostasis: loss of normal proteins and accumulation of misfolded proteins

Exacerbated by chronic diseases, especially those associated with prolonged inflammation, and by stress; slowed down by calorie restriction and exercise

45
Q

Cellular aging: causes & mxms

A
46
Q

Telomeres and senescence

A
47
Q

Concept Map of Major Terms in Pathophysiology

A

STRESSOR
- Interferes with normal cell function

CELL INJURY or ADAPTATION or COUNTERATTACK

CELL INJURY
- Decreases cell function

ADAPTATION
- Cell or system reacts to restore normal function

COUNTERATTACK
- Cells and systems react to reduce or remove the stressor

cell injury to HEALING

healing
- Repairs injury

CELL INJURY or ADAPTATION or COUNTERATTACK can all go to signs & symptoms

SIGNS: Can be detected or measured

SYMPTOMS: The patient can feel

COMPLICATIONS: Occur when injury, adaptation, and counterattacks act as new stressors

48
Q

Inflammation

A

◼ Reaction of vascularized tissue to local injury

◼ Reaction develops in
steps:
1. recognition of the
offending agent;
2. recruitment of blood cells
and proteins to the site;
3. removal of the offending
agent;
4. regulation of the
reaction;
5. repair of injured tissue

49
Q

Inflammation: Causes

A

Many and varied
◼ Response to infectious microorganisms
◼ Trauma
◼ Surgery
◼ Caustic chemicals
◼ Heat and cold extremes
◼ Ischemic damage to tissues
◼ Immune rxns (hypersensitivity, autoimmunity)

50
Q

Acute vs. Chronic Inflammation

A

Difference dependent upon:
◼ Persistence of injury
◼ Clinical symptoms
◼ Nature of the inflammatory response

Acute:
◼ Accumulation of fluid and plasma components in
tissue
◼ Intravascular stimulation of platelets ◼ Presence of PMNs

Chronic:
◼ Lymphocytes, plasma cells, macrophages

51
Q

acute inflammation

A

onset
- fast: minutes to hours

cellular infiltrate
- mainly neutrophils (PMNs)

tissue injury
- usually mild and self-limited

fibrosis
- none

local & systemic signs
- prominent

52
Q

chronic inflammation

A

onset
- slow: days

cellular infiltrate
- monocytes/macrophages; lymphocytes

tissue injury
- may be significant

fibrosis
- maybe severe and progressive

local & systemic signs
- variable; usually modest

53
Q

Acute Inflammation

A

Short: minutes to days

Hallmarks:
◼ Rubor (redness)
◼ Dolor (pain)
◼ Calor (heat)
◼ Tumor (swelling)
◼ Functio laesa (loss of function)

Anything ending in –itis: describes an inflammatory state

54
Q

Acute inflammation (cont.)

A

Outcomes:
◼ Resolution
◼ Abscess
◼ Scar
◼ Persistent inflammation

Stages:
◼ Vascular (hemodynamic) stage
◼ Cellular stage

55
Q

Acute inflammation (cont.)

A

Vascular stage:
◼ Transient vasoconstriction
◼ Rapid vasodilation of arterioles and venules supplying injured area
◼ Increased permeability of vessel endothelial cell barrier

Cellular stage:
◼ PMNs initially
◼ Macrophages later

56
Q

Increased vascular permeability

A
57
Q

Circulating PMNs

A

Chemotactic factors

to

Margination & adherence

to

Emigration

to

Chemotactic migration

to

Phagocytosis

58
Q

Leukocyte migration

A
59
Q

Inflammatory mediators

A

Tissue injury
*Trauma
*Ischemia
*Neoplasm
*Infection
*Particle (e.g., asbestos)

Vasoactive mediators
*Histamine
*Serotonin
*Bradykinin
*Anaphylatoxins
*Leukotrienes/prostaglandins *Platelet activating factor

Chemotactic factors
*C5a
*Lipoxygenase products (e.g., LTB4) *Formylated products
*Lymphokines *Monokines

60
Q

◼ Vasoactive mediators

A

◼ Histamine
◼ Serotonin
◼ Bradykinin
◼ Anaphylatoxins
◼ Leukotrienes/prostaglandins ◼ Platelet activating factor

to

Increased vascular permeability

to

edema

61
Q

Chemotactic factors

A

◼ Histamine
◼ Serotonin
◼ Bradykinin
◼ Anaphylatoxins
◼ Leukotrienes/prostaglandins ◼ Platelet-activating factor

to

Recruitment and stimulation of inflammatory cells

can either go to acute inflammation or chronic inflammation

Acute inflammation
*PMNs
*Macrophages

Chronic inflammation
*Macrophages
*Lymphocytes
*Plasma cells

62
Q

Vasoactive mediators

A

plasma
- Complement activation: Anaphylatoxins (C3a, C5a)
◼ Hageman factor activation: Bradykinin

cell
◼ Mast cell/basophil degranulation:
Histamine
◼ Platelets: Serotonin
◼ Inflammatory cells: Leukotrienes, prostaglandins, platelet-activating factor

63
Q

Chemotactic factors

A

plasma
◼ Complement activation: C5a, C3a

cell
◼ Cell membrane phospholipids:
Lipoxygenase products (e.g., LTB4)
◼ Inflammatory cells: Chemokines = Lymphokines, monokines
◼ Bacterial and mitochondrial: Formylated products

64
Q

Vascular Response

A

Arachidonic acid released from injured cell membranes

to

Cyclooxygenase/ Lipoxygenase pathways

Prostaglandins/ leukotrienes

to

vasodilation and increased capillary permeability

histamine released from injured cells
can go to Vasodilation and increased capillary permeability

Vasodilation and increased capillary permeability can go to calor (heat) or rubor (redness)

Vasodilation and increased capillary permeability to exudate

exudate to tumor or dolor (pain)

exudate to toxin dilution

exudate to Decreased blood flow out of injured area

65
Q

Cellular Response

A

Phagocytes enter injured area by:
- margination
- pavementing
- emigration
- chemotaxis

chart (how do you study this ah….)

66
Q

Origins of inflammatory mediators

A
67
Q

Principal Inflammatory Mediators

A

histamine
- sources: mast cells, basophils, platelets
- actions: vasodilation, increased vascular permeability, endothelial activation

prostaglandins
- sources: mast cells, leukocytes
- actions: vasodilation, pain, fever

leukotrienes
- sources: mast cells, leukocytes
- actions: increased vascular permeability, endothelial activation chemotaxis, leukocyte adhesion, and activation

cytokines (ex: TNF, IL-1, IL-6)
- sources: macrophages, endothelial cells, mast cells
- actions: local: endothelial activation (expression of adhesion molecules); systemic: fever, metabolic abnormalities, hypotension (shock)

chemokines
- sources: leukocytes, activated macrophages
- actions: chemotaxis, leukocyte activation

platelet-activating factor
- sources: leukocytes, mast cells
- actions: vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst

complement
- sources: plasma (produced in the liver)
- actions: leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation)

kinins
- sources: plasma (produced in the liver)
- actions: increased vascular permeability, smooth muscle contraction, vasodilation, pain

68
Q

Principal Actions of AA Metabolites in Inflammation

A

vasodilation:
- eicosanoids: prostaglandins PG12 (prostacyclin), PGE1, PGE2, PGD2

Vasoconstriction
- eicosanoids: thromboxane A2, Leukotrienes C4, D4, E4

increased vascular permeability
- eicosanoids: leukotrienes C4, D4, E4

Chemotaxis, leukocyte adhesion
- eicosanoids: leukotriene B4

69
Q

Outcomes of Acute Inflammation

A

Acute inflammation
- injury: tissue necrosis, bacterial infection, toxins, trauma
- vascular changes: vasodilation, increased vascular permeability

healing: resolution & scarring (fibrosis)

resolution:
clearance of harmful stimuli, clearance of mediators and acute inflammatory cells, replacement of injured cells, normal function

scarring:
loss of function, connective tissue, fibroblasts

or from acute inflammation, the cell can go to chronic inflammation and then can go to scarring

with chronic inflammation
- chronic infectious
- persistent injury
- autoimmune and allergic disease

70
Q

Inflammation and Healing

A

The inflammatory response
◼ Acute inflammation
◼ Chronic inflammation
◼ Manifestations of inflammation

Tissue repair and wound healing
◼ Tissue repair
◼ Wound healing

71
Q

Chronic inflammation

A

Long and self-perpetuating: weeks to years
◼ Contains and removes pathologic agent/process

Characteristic cells:
◼ Macrophages
◼ Lymphocytes
◼ Fibroblasts: increased risk of scarring and deformity than acute inflammation

Typical causative agents:
◼ Recurrent or progressive acute inflammation
◼ Low-grade, persistent irritants, with the inability to penetrate deeply or spread rapidly

72
Q

Chronic inflammation

A

Two patterns:
◼ Nonspecific chronic inflammation ◼ Granulomatous inflammation

73
Q

Inflammation and Healing

A

The inflammatory response
◼ Acute inflammation
◼ Chronic inflammation
◼ Manifestations of inflammation

Tissue repair and wound healing
◼ Tissue repair
◼ Wound healing

74
Q

Inflammation Manifestations

A

Local
◼ Swelling
◼ Exudates: serous, hemorrhagic, fibrinous, membranous, purulent (suppurative)
◼ Abscess
◼ Ulceration

Systemic
◼ Acute-phase response
◼ Alterations in WBC count
◼ Fever

75
Q

Acute-phase response

A

Leukocytes release interleukins and tumor necrosis factor
◼ Affect thermoregulatory center → fever
◼ Affect central nervous system → lethargy
◼ Skeletal muscle breakdown

Liver makes fibrinogen and C-reactive protein
◼ Facilitate clotting
◼ Bind to pathogens
◼ Moderate inflammatory responses

76
Q

Tissue Regeneration and Repair

A

tissue regeneration: repair of injured tissue with cells of same parenchymal type
◼ Parenchymal tissue ◼ Stromal tissue
◼ Labile cells
◼ Stable cells
◼ Permanent (fixed) cells

Connective tissue repair: scar tissue substituted for parenchymal cells of injured tissue

77
Q

Wound healing

A

Healing depends upon extent of tissue loss and occurs via:
◼ Primary intention
◼ Secondary intention

Phases of healing:
◼ Inflammatory phase: just seen
◼ Proliferation phase: Angiogenesis and growth of granulation tissue; emigration of fibroblasts and deposition of extracellular matrix
◼ Remodeling phase: Maturation and reorganization of the fibrous tissue

78
Q

Factors Affecting Wound Healing

A

◼ Malnutrition
◼ Blood flow and O2 delivery
◼ Impaired inflammation and immune responses
◼ Infection, wound separation, foreign bodies
◼ Age

79
Q

Cell differentiation and growth

A

Cell cycle
◼ G1: RNA and protein synthesis and cell
growth; variable time*
◼ S: DNA synthesis w/ 2 sets of chromosomes; 10 – 20 hours
◼ G2: premitotic; 2 – 10 hours
◼ M: mitosis; 0.5 – 1 hour
◼ G0: resting phase; variable time*

  • Duration is dependent upon tissue type
80
Q

Cell cycle

A

Labile cells: cells that continuously multiply and divide throughout life. Labile cells replace the cells that are lost from the body.

Cyclins
- ensure the cell has made proteins needed for chromo-some separation
- check for correct DNA duplication
- measure whether the cell is large enough to divide

81
Q

RB

A

Role in regu- lating G1–S check- point of cell cycle

82
Q

Cell differentiation and growth

A

Cell proliferation: process by which cells divide and reproduce

3 general types of cells with regard to differentiation
◼ Highly differentiated
◼ Progenitor cells
◼ Stem cells

83
Q

Cell differentiation and growth

A

Cell differentiation: Orderly, stepwise process
Progenitor cells: partially differentiated, replace mature cells of same cell lineage

Stem cells:
◼ Unipotent - red blood cell
◼ Oligopotent - myeloid cell
◼ Pluripotent - stem cell, can becom anything

84
Q

Terminology

A

Tumor: any condition leading to swelling but often used to mean neoplasm

Neoplasm: abnormal mass of tissue in which growth exceeds, and is uncoordinated with, that of normal tissues
◼ Benign: well-differentiated cells, clustered together in a single mass; usually do not cause death
◼ Malignant: less well differentiated, can break loose (metastasize); death if untreated or uncontrolled
◼ -oma: suffix added to parenchymal tissue type to denote tumor name

85
Q

Terminology

A

Benign
- Cell characteristics: Well- differentiated; resemble cells in tissue of origin
- Rate of growth: Progressive and slow; may stop or regress
- Mode of growth: Expansion w/o invasion; usually encapsulated
- Metastasis: No

Malignant
- Cell characteristics: undifferentiated; Undifferentiated, w/ anaplasia and atypical structure; little or no resemblance to tissue of origin
- Rate of growth: Variable, depends on the level of differentiation
- Mode of growth: invasive; sends out processes to infiltrate surrounding tissues
- Metastasis: yes

86
Q

Benign vs. Malignant

A

◼ When differentiated, “working” cells mutate, they form differentiated “working” tumors— benign tumors

◼ When undifferentiated, rapidly dividing cells mutate, they form rapidly dividing tumors—malignant tumors

87
Q

Cancer cell characteristics

A

Fail to undergo normal cell proliferation and differentiation
◼ Believed that cancer cells develop from mutations occurring during differentiation
◼ Mutations early in process: tumor poorly differentiated and highly malignant
◼ Mutations later in process: tumor more fully differentiated and less malignant
◼ Grading of tumor based upon degree of differentiation and number of proliferating cells

88
Q

Gleason grading: prostate

A

look at histology to see what they look like anxd to seeif they look like normal cells

◼ Loss of contact inhibition
◼ Loss of cohesiveness and adhesion
◼ Impaired cell-cell communication
◼ Expression of altered tissue antigens
◼ Production of degradative enzymes - Allowing invasion and metastasis

89
Q

cancer: hallmarks and enabling factors

A

deregulatinng cellular energetics

sustaining proliferative signaling

inducing angiogenesis

resisting cell death

genomic instability (mutator phenotype)

activing invasion and metastaus

tumro promoting inflammation

enabling immortality

evading growth suppressors

avdoing immune destruction

90
Q

Tissue invasion and metastasis

A

Seeding
◼ Entering body cavity

Metastasis
◼ Leave 1o tumor
◼ Invade ECM
◼ Enter blood/lymph
◼ Survive blood/lymph
◼ Location for growth
◼ Invade tissue & grow

91
Q

Tumor Growth

A

Depends upon:
◼ Number of cells dividing
◼ Duration of cell cycle
◼ Number of cells being lost compared to number being produced

Tumor growth due to increased number of dividing cells
◼ Cells don’t die on schedule
◼ Lack growth factors for entering Go phase

Growth limited by blood supply and nutrients

92
Q

Oncogenesis

A

genetic mxm whereby normal cells are transformed into cancer cells

Proto-oncogenes
◼ Growth stimulating regulatory genes
◼ Usually encode growth factors or second messengers that stimulate growth

Tumor suppressor genes (anti-oncogenes)
◼ Growth inhibiting regulatory genes

Genes controlling apoptosis
DNA repair genes

93
Q

chart

A
94
Q

TSG mutation

A
95
Q

image

A
96
Q

Cancer cell transformation by chemicals

A

◼ Multi-step process whereby normal cells become cancer cells
◼ Initiation
◼ Promotion
◼ Progression

97
Q

Cancer risk factors

A

◼ Interactions among multiple risk factors or repeated exposure to carcinogens necessary for cancer to develop
◼ Hereditary
◼ Hormones
◼ Obesity
◼ Chemical carcinogens
◼ Radiation
◼ Viruses
◼ Immune dysfunction

98
Q

Clinical Manifestations of Cancer

A

◼ Changes in organ function (e.g., organ damage, inflammation, and failure)
◼ Local effects of tumors (e.g., compression of nerves or veins, gastrointestinal obstruction)
◼ Tissue integrity: nonspecific signs of tissue breakdown (e.g., protein wasting, bone breakdown)
◼ Paraneoplastic syndromes: Ectopic hormones secreted by tumor cells

99
Q

Clinical Manifestations of Cancer (cont.)

A

Cancer cachexia
◼ Weight loss
◼ Muscle wasting
◼ Weakness
◼ Anorexia
◼ Anemia

100
Q

Cancer treatment

A

◼ Surgery
◼ Radiation
◼ Chemotherapy
◼ Hormonal
◼ Biotherapy (immunotherapy, biologic
response modifiers)
◼ Targeted
◼ Transplantation
◼ Hyperthermia
◼ Photodynamic

101
Q

Genetic analysis: identify mutations for drug targets

A
102
Q

Using molecular information to guide CA therapy

A
103
Q
A